Camber Capital Management LP
Filing Date
Global Rank
#1,626
/ 7,991
▼ 730
Top Industry
Healthcare Plans
23.9%
3Y Alpha vs SPY
-12.2%
Period ended 12 months ago
Filed Aug 14, 2025 · 10mo
22 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+28.9%
SPY
+76.5%
Annualised alpha
-12.0%
Max drawdown
−21.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
24 positions · as of Jun 30, 2025 · Δ vs Mar 31, 2025Top Position
29.4%
−3.2 pts
Top 5
60.2%
−6.5 pts
Top 10
80.4%
−3.8 pts
HHI
1,230
Diversified−216
Portfolio Trend
22 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 70.6% | $741,343,750 |
| Unclassified | 29.4% | $308,925,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | +100,000 | 600,000 | $32,982,000 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PFE | Pfizer Inc | −7,800,000 | 1,500,000 | $36,360,000 | |
| VTRS | Viatris Inc | −4,750,000 | 2,750,000 | $24,557,500 | |
| BKD | Brookdale Senior Living Inc. | −4,100,000 | 2,150,000 | $14,964,000 | |
| BAX | Baxter International Inc | −2,900,000 | 2,850,000 | $86,298,000 | |
| EVH | Evolent Health, Inc. | −2,150,000 | 850,000 | $9,571,000 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −1,250,000 | 1,000,000 | $91,210,000 | |
| CVS | CVS HEALTH Corp | −1,200,000 | 1,050,000 | $72,429,000 | |
| CON | Concentra Group Holdings Parent, Inc. | −1,200,000 | 400,000 | $8,228,000 | |
| SPY | Spdr S&P 500 ETF Trust | −1,000,000 | 500,000 | $308,925,000 | |
| DNLI | Denali Therapeutics Inc. | −850,000 | 400,000 | $5,596,000 | |
| ANAB | Anaptysbio, Inc | −625,000 | 125,000 | $2,775,000 | |
| TBPH | Theravance Biopharma, Inc. | −550,000 | 450,000 | $4,963,500 | |
| GMED | Globus Medical Inc | −450,000 | 800,000 | $47,216,000 | |
| HUM | Humana Inc | −425,000 | 300,000 | $73,344,000 | |
| MYGN | Myriad Genetics Inc | −350,000 | 2,000,000 | $10,620,000 | |
| ASND | Ascendis Pharma A/S | −100,000 | 250,000 | $43,150,000 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PTCT | Ptc Therapeutics, Inc. | 1,500,000 | $76,440,000 | |
| CI | Cigna Group | 200,000 | $65,800,000 | |
| SRPT | Sarepta Therapeutics, Inc. | 800,000 | $51,056,000 | |
| IONS | Ionis Pharmaceuticals Inc | 725,000 | $21,873,250 | |
| MLTX | MoonLake Immunotherapeutics | 441,000 | $17,229,870 | |
| TXG | 10x Genomics, Inc. | 1,000,000 | $8,730,000 | |
| GPCR | Structure Therapeutics Inc. | 300,000 | $5,193,000 | |
| GMAB | Genmab A/S | 50,000 | $979,000 | |
| No positions match the current search. | ||||
24 positions ·
$1,050,268,750 total
· as of Jun 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
Reduced | 500,000 | $308,925,000 | 29.41% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Reduced | 1,000,000 | $91,210,000 | 8.68% | |
| BAX |
Baxter International Inc
Healthcare
|
Reduced | 2,850,000 | $86,298,000 | 8.22% | |
| HUM |
Humana Inc
Healthcare
|
Reduced | 300,000 | $73,344,000 | 6.98% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
Reduced | 1,050,000 | $72,429,000 | 6.90% | |
| GMED |
Globus Medical Inc
Healthcare
|
Reduced | 800,000 | $47,216,000 | 4.50% | |
| ICLR |
Icon PLC
Healthcare
|
NEW | 300,000 | $43,635,000 | 4.15% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 250,000 | $43,150,000 | 4.11% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 500,000 | $39,580,000 | 3.77% | |
| GSK |
GSK plc
Healthcare
|
Held | 1,000,000 | $38,400,000 | 3.66% | |
| PFE |
Pfizer Inc
Healthcare
|
Reduced | 1,500,000 | $36,360,000 | 3.46% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 600,000 | $32,982,000 | 3.14% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
NEW | 100,000 | $31,197,000 | 2.97% | |
| VTRS |
Viatris Inc
Healthcare
|
Reduced | 2,750,000 | $24,557,500 | 2.34% | |
| BKD |
Brookdale Senior Living Inc.
Healthcare
|
Reduced | 2,150,000 | $14,964,000 | 1.42% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
NEW | 850,000 | $14,713,500 | 1.40% | |
| MYGN |
Myriad Genetics Inc
Healthcare
|
Reduced | 2,000,000 | $10,620,000 | 1.01% | |
| EVH |
Evolent Health, Inc.
Healthcare
|
Reduced | 850,000 | $9,571,000 | 0.91% | |
| CON |
Concentra Group Holdings Parent, Inc.
Healthcare
|
Reduced | 400,000 | $8,228,000 | 0.78% | |
| INGN |
Inogen Inc
Healthcare
|
Held | 975,000 | $6,854,250 | 0.65% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Reduced | 400,000 | $5,596,000 | 0.53% | |
| TBPH |
Theravance Biopharma, Inc.
Healthcare
|
Reduced | 450,000 | $4,963,500 | 0.47% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Reduced | 125,000 | $2,775,000 | 0.26% | |
| OSUR |
Orasure Technologies Inc
Healthcare
|
Held | 900,000 | $2,700,000 | 0.26% |